Gabapentin - CAS 60142-96-3
Catalog number: 60142-96-3
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C9H17NO2
Molecular Weight:
171.24
COA:
Inquire
Targets:
Calcium Channel
Description:
Gabapentin is structurally similar to GABA and is reported in various research studies to increase GABA concentrations within the brain. Gabapentin is also noted to bind to a novel site on voltage-sensitive Ca2+ channels. Additionally, Gabapentin is reported to demonstrate inhibition of dopamine release from caudate nucleus, prevent neuronal cell death, and is antinociceptive.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1.The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome.
Avidan AY1, Lee D2, Park M3, Jaros MJ4, Shang G5, Kim R5. CNS Drugs. 2016 Apr 11. [Epub ahead of print]
OBJECTIVE: The aim was to assess gabapentin enacarbil (GEn) treatment effects on quality of life (QOL) and mood in adults with moderate-to-severe primary restless legs syndrome (RLS).
2.Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial.
Lewis SC1, Bhattacharya S2, Wu O3, Vincent K4, Jack SA5, Critchley HO6, Porter MA2, Cranley D7, Wilson JA8, Horne AW6. PLoS One. 2016 Apr 12;11(4):e0153037. doi: 10.1371/journal.pone.0153037. eCollection 2016.
TRIAL REGISTRATION: Controlled-Trials.com ISRCTN45178534.
3.Diabetic Sensory and Motor Neuropathy.
N Engl J Med. 2016 Apr 13. [Epub ahead of print]
Diabetic Sensory and Motor Neuropathy Clinical Practice, N Engl J Med 2016;374:1455-1464. In Table 1 (page 1457), in the second entry in the third column, "impaired autonomic dysfunction" should have been "impaired autonomic function." The third entry in the first column should have been "Recognize clinical implications." The fifth entry in the first column should have been "Consider differential diagnosis." In Table 2 (pages 1460-1), the initial dose of topiramate should have been 25 mg/day, and the effective dose 25-100 mg/day. For gabapentin, the upper bound of the confidence interval for the number needed to treat should have been 8.3. The effective dose of amitriptyline should have been 25-150 mg/day. The effective dose of tramadol should have been 100-200 mg/day, and the number needed to treat should have been 4.7. In the final sentence of the second paragraph under Areas of Uncertainty (page 1461), the term "(frank deficiency)" should not have appeared.
4.Analyzing Relationship Between Monoclonal Gammopathy of Undetermined Significance (MGUS) with Different Types of Neuropathy: An Observational Study.
Nabi S1, Kahlon P1, Bozorgnia F2, Arshad A3, Saleem A4, Kuriakose P5. Indian J Hematol Blood Transfus. 2016 Jun;32(2):186-92. doi: 10.1007/s12288-015-0547-9. Epub 2015 May 28.
To analyze multiple variables, including immunoglobulin subtypes in patients with monoclonal gammopathy of undetermined significance (MGUS) and different types of neuropathy. This was a retrospective, single center study done in a tertiary care hospital in the United States. The data was collected for years 2001-2011. Inclusion criteria were the presence of MGUS and neuropathy. Exclusion criteria were the presence of other factors such as diabetes, vitamin B12 deficiency, alcoholism etc. which can cause neuropathy. Patients with IgM MGUS were compared with patients having Non-IgM MGUS. A total of 281 patients were analyzed in this study. The average age at the time of diagnosis of MGUS and neuropathy was 68 years. The most common type of neuropathy was sensorimotor peripheral neuropathy (46 %). The most common location of neuropathy was the lower extremities (68 %). Among our patients, 52 % had their neuropathy symptoms for 1-5 years before presenting to the clinic.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Calcium Channel Products


CAS 111470-99-6 Amlodipine Besylate

Amlodipine Besylate
(CAS: 111470-99-6)

Amlodipine Besylate is a long-acting calcium channel blocker, used to lower blood pressure and prevent chest pain.

CAS 1841-19-6 Fluspirilene

Fluspirilene
(CAS: 1841-19-6)

Fluspirilene, with antipsychotic activity, is a non-competitive antagonist of agonist-activated L-type calcium channels (IC50 = 0.03 µM). Fluspirilene is also a...

CAS 99254-95-2 McN5691

McN5691
(CAS: 99254-95-2)

McN5691, an antihypertensive agent, is a voltage-sensitive calcium channel blocker.

CAS 75530-68-6 Nilvadipine

Nilvadipine
(CAS: 75530-68-6)

Nilvadipine is a potent calcium channel blocker with an IC50 of 0.03 nM.

CAS 116308-56-6 Watanipidine monohydrochloride

Watanipidine monohydrochloride
(CAS: 116308-56-6)

Watanipidine, also called as AE 0047 or Calbren, is a calcium channel antagonist.

CAS 610300-07-7 Imagabalin

Imagabalin
(CAS: 610300-07-7)

Imagabalin acts as a ligand for the α2δ subunit of the voltage-dependent calcium channel, which has some selectivity for the α2δ1 subunit over α2δ2. It has anxi...

CAS 15826-37-6 Disodium Cromoglycate

Disodium Cromoglycate
(CAS: 15826-37-6)

Disodium Cromoglycate is an antiallergic drug with IC50 of 39 μg/mL.

GV-58
(CAS: 1402821-41-3)

GV-58, a pupin derivative, has been found to be a P/Q-type Ca²⁺-channel agonist that could be used to against neuromuscular weakness. IC50: 7.21/8.81 uM (N-type...

CAS 30484-77-6 Flunarizine Dihydrochloride

Flunarizine Dihydrochloride
(CAS: 30484-77-6)

Flunarizine 2HCl is a dihydrochloride salt form which is a calcium channel blocker with a Ki of 68 nM.

CAS 57265-65-3 Calmidazolium chloride

Calmidazolium chloride
(CAS: 57265-65-3)

Calmidazolium chloride has been found to be a calcium channel protein inhibitor as well as a calmodulin antagonist.

CAS 74764-40-2 Bepridil hydrochloride hydrate

Bepridil hydrochloride hydrate
(CAS: 74764-40-2)

Bepridil is an amine Calcium channel antagonist that used to treat angina. But it is no longer sold in the United States. It may be a possible option in the tre...

CAS 544478-19-5 MRS 1845

MRS 1845
(CAS: 544478-19-5)

MRS 1845 is a potent SOCE inhibitor that can block Ca2+ capacitative entry resulting in an antiinflammatory effect. MRS 1845 inhibits capacitative Ca2+ influx i...

CAS 136-47-0 Tetracaine Hydrochloride

Tetracaine Hydrochloride
(CAS: 136-47-0)

Tetracaine hydrochlorideis a hydrochloride salt form of tetracaine which is a potent local anaesthetic and a channel function allosteric inhibitor.

Etripamil
(CAS: 1593673-23-4)

Etripamil, a benzoates derivative, has been found to be a calcium channel antagonist that could be used against hypertension and arrhythmic. It is currently und...

CAS 79700-61-1 Dopropidil

Dopropidil
(CAS: 79700-61-1)

Dopropidil, also called as ORG 30701, is a cardioactive drug to be classified as a calcium antagonist with combined class I and class VI antiarrhythmic properti...

Ned K

Ned K, a NAADP inhibitor, prevents Ca2+ oscillations in rat cardiomyocytes in vitro during simulated ischemia and reperfusion, but exhibits no significant effec...

CAS 41332-24-5 NP-118809

NP-118809
(CAS: 41332-24-5)

NP-118809 is a N-type calcium channel blocker exhibits both anti-allodynic and anti-hyperalgesic activity in the spinal nerve ligation model of neuropathic pain...

CAS 91599-74-5 Benidipine HCl

Benidipine HCl
(CAS: 91599-74-5)

Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.

CAS 212778-82-0 Elpetrigine

Elpetrigine
(CAS: 212778-82-0)

Elpetrigine, also known as GW 273293 and JZP-4, has a blocking effect on calcium channels and potassium channels which has been in clinical bipolar disorders an...

CAS 39562-70-4 Nitrendipine

Nitrendipine
(CAS: 39562-70-4)

Nitrendipine is a dihydropyridine calcium channel blocker with an IC50 of 95 nM.It is used in the treatment of primary (essential) hypertension to decrease bloo...

Chemical Structure

CAS 60142-96-3 Gabapentin

Quick Inquiry

Verification code

Featured Items